Search results
Found 31159 matches for
We are lucky to have Dr Filip Knop from Jen Holst's group in Copenhagen visiting us on the 15th-16th May to help us set up techniques for measuring the incretin effect in OCDEM.
©
Permission required for use. Credit: Doug Vernimmen
BTRU Patient Partners supporting training of the early career researchers
NIHR BTRU PCT
30 October 2024
Evelyn Chakera and Julie Richardson-Abraham, BTRU Patient Partners, supported a training day for early career researchers - organised by the Advanced Therapy Academy.
Under-40s diagnosed with type 2 diabetes have a mortality rate four times higher than the general population
DTU General OCDEM Publication Research
24 October 2024
People diagnosed with type 2 diabetes before 40 years of age, have nearly four times the risk of death compared with the general UK population, a new study carried out at the University of Oxford’s Radcliffe Department of Medicine has found.
35 Years of the MRC WIMM
General MRC WIMM
23 October 2024
In 1989, Sir David Weatherall founded the Institute of Molecular Medicine to bridge the gap between basic science and clinical medicine. To mark 35 years since the MRC WIMM opened its labs, we're looking back on some of our highlights and achievements.
New Type 1 Diabetes Grand Challenge funding to develop drugs from bugs
CVM General OCDEM Research
22 October 2024
Today the Type 1 Diabetes Grand Challenge, a trailblazing partnership between the Steve Morgan Foundation, Diabetes UK, and Breakthrough T1D (formerly JDRF) has announced funding for a cutting-edge research project led by researchers in the Radcliffe Department of Medicine, which could bring us closer to a cure for type 1 diabetes.
Professor Robin Choudhury publishes a new book about the heart
CVM General Publication
17 October 2024
Robin Choudhury, Professor of Cardiovascular Medicine, has written a book about the art and science of the heart. Here he answers some questions about the origins and highlights of the project.
Advanced Therapy Academy Training Day
NIHR BTRU PCT
16 October 2024
The BTRU in Precision Cellular Therapeutics are proud to have hosted Advanced Therapy Academy Training Day on the 20 September 2024 at the Institute of Developmental & Regenerative Medicine, University of Oxford.
New biomarker and therapeutic target identified for blood cancers
General MRC MHU MRC WIMM
10 October 2024
Research from the MRC Molecular Haematology Unit has revealed a protein called galectin-1 as a key marker for disease progression and as a promising therapeutic target for patients with myeloproliferative neoplasms (a type of blood cancer).
New Cross-Cutting Research Theme Lead for Advanced Therapy Medicinal Products
Department General NDCLS Research
8 October 2024
Researchers develop new tool to better predict acute myeloid leukaemia outcomes in older patients
General MRC MHU MRC WIMM Publication Research
17 September 2024
In a study published in the Journal of Clinical Oncology, an international research team has used machine learning to improve risk stratification for patients over 60 diagnosed with acute myeloid leukaemia, an aggressive type of blood cancer.
Hydroxychloroquine provides moderate COVID-19 prevention
DTU
16 September 2024
COPCOV, the world’s largest COVID-19 chemoprevention study, published results today showing that hydroxychloroquine (HCQ) has a moderate benefit in preventing COVID-19. The COPCOV trial was led globally by the Mahidol Oxford Tropical Medicine Research Unit (MORU), Thailand. The Diabetes Trials Unit (DTU) was the UK coordinating centre for the trial, helped develop the protocol, and was responsible for managing UK sites, approvals and procedures.
Patients receiving steroids are more than twice as likely to develop diabetes, UK study has found
DTU General OCDEM Research
10 September 2024
Patients who are being treated with systemic glucocorticoids are more than twice as likely to develop diabetes as those not receiving the treatment, a new study by researchers at the Radcliffe Department of Medicine’s Diabetes Trial Unit has found.
RDM researchers among world-leading cardiologists at ESC Congress 2024
CVM General Research
29 August 2024
World-leading cardiology experts are to convene at the annual European Society of Cardiology (ESC) Congress in London from tomorrow (Friday 30 August).
Senior Fellowship awarded to Beth Psaila
General MRC MHU MRC WIMM
28 August 2024
Congratulations to Beth Psaila, who has been awarded a Senior Fellowship funded by Cancer Research UK in partnership with Rosetrees Trust.
Michael Zimmermann awarded Full Professor title
Awards General
27 August 2024
Congratulations to Professor Michael Zimmermann, who has been awarded the title of Full Professor in the University’s 2024 Recognition of Distinction exercise.
Of Mice and Men - Researchers demonstrate evolutionary conservation of blood stem cell subtypes
General MRC MHU MRC WIMM Publication Research
27 August 2024
Researchers from the MRC Weatherall Institute of Molecular Medicine (WIMM) have shown that blood stem cell subtypes found in mice also exist in humans. This provides important information for research into therapies to alleviate the negative effects of aging.
RDM researchers showcase at IF Oxford 2024 – book now
22 August 2024
IF Oxford returns as a digital and in-real-life science and ideas Festival with events running throughout October 2024.
Structure of a key “trigger” of the immune response solved
MRC WIMM Publication Research
15 August 2024
Grant awarded to develop artificial intelligence tools to understand the bone marrow landscape
NDCLS Research
14 August 2024
Our researchers have received $200,000 to develop artificial intelligence tools to better diagnose what goes wrong in the bone marrow of myeloproliferative neoplasm (MPN) patients.
BTRU in Precision Therapeutics holds second Annual BTRU event
7 August 2024
The NIHR Blood and Transplant Research Unit (BTRU) in Precision Cellular Therapeutics (BTRU) had its second Annual BTRU Event on the 17 June 2024 at Edgbaston Park Hotel, University of Birmingham.